Coverage
-
April 20, 2016
A Delaware federal judge on Wednesday upheld the validity of five patents licensed by Pfizer Inc. protecting its Toviaz overactive-bladder treatment, dealing a blow to Sandoz Inc. and other drug companies accused of infringement in Pfizer's consolidated suit.
4 other articles on this case.
View all »